about US

Who we are

Hippocrates Research (HR) is a Contract Research Organization (CRO) within the Hippocrates Group, delivering integrated, high-quality clinical research services.

Starting from our sponsors’ specific needs, we adopt a tailored, performance-driven approach, integrating key performance indicators (KPIs) into both workflow and data management systems. This ensures the achievement of agreed objectives while providing high-quality, end-to-end services at competitive costs.

Our management team, organized into dedicated research units, brings over 30 years of experience in the pharmaceutical industry. This expertise is continuously strengthened through structured national and international training programs, including advanced courses in clinical research, problem-solving, organizational management, and communication.

HR combines medical and pharmaceutical expertise with strong quality assurance, regulatory competence, and operational flexibility, all focused on achieving sponsor objectives and ensuring long-term customer satisfaction.

Hippocrates Research supports sponsors throughout the entire product development lifecycle, from early clinical development to product launch, leveraging the complementary expertise of the Hippocrates Group.

Through a multidisciplinary team of experts in medical affairs, regulatory affairs, quality assurance, clinical operations, market access advisory, scientific communication, and real-world evidence (RWE), HR is able to support its clients from project design through full study execution.

This integrated approach enables streamlined decision-making, operational efficiency, and shortened time-to-market for innovative products, while ensuring the highest standards of quality and regulatory compliance.

The group

The Hippocrates Group also includes Hippocrates Holding, the Group’s capital company; Hippocrates Sintech, specialized in information technology and healthcare and pharmaceutical communication; and Hippocrates Pharma Genetics, operating in the fields of pharmacogenetics and pharmacogenomics.

 Hippocrates Research works with both national and international sponsors, ensuring a high level of expertise in all aspects of the Italian regulatory framework. Our service portfolio spans from molecule selection and identification to feasibility studies and full project management of Phase I–IV clinical trials.

In addition, HR conducts observational, prospective, spontaneous, and epidemiological studies, and supports clients through integrated concept-to-development projects with built-in marketing strategies.

we support

Hippocrates Research was founded in Genoa

First study conducted with our GP Network

HR obtains the Quality System ISO 9001 certification

HR commits to the UN Global Compact corporate responsibility initiative and its principles

Hippocrates Sintech was founded in Genoa

Hippocrates Pharma Genetics was founded in Rome

AIFA Inspection with positive outcome

First SaMD pre-market study managed

UNI EN ISO 9001:2015 certification renewed for our Quality Management System


Gender Equality and ECOVADIS certifications


Opening of the Swiss branch as HR Swiss

Our stories

over the years

Our stories

over the years

Hippocrates Research was founded in Genoa

First study conducted with our GP Network

HR obtains the Quality System ISO 9001 certification

HR commits to the UN Global Compact corporate responsability initiative and its principles


Hippocrates Sintech was founded in Genoa

Hippocrates Pharma Genetics was founded in Rome

AIFA Inspection with positive outcome

Launch of the first digital interventional clinical trial during the SARS-CoV-19 pandemic


First SaMD pre-market study managed

Cookie Policy Privacy Policy Cookie Policy